What is Adipex-P?
Adipex-P (phentermine) is a prescription medicine similar to amphetamine. Phentermine stimulates the central nervous system (nerves and brain), which increases your heart rate and blood pressure and decreases your appetite.
this pill is used together with diet and exercise to treat obesity, especially in people with risk factors such as high blood pressure, high cholesterol, or diabetes.
Do not use Adipex-P if you are pregnant or breast-feeding a baby.
You should not use this if you have a history of heart disease (coronary artery disease, heart rhythm problems, or congestive heart failure), previous stroke, severe or uncontrolled high blood pressure overactive thyroid, glaucoma, extreme agitation or nervousness, a history of drug abuse, or if you take other diet pills.
Do not use this medicine if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, phenelzine, rasagiline, selegiline, or tranylcypromine, or if you have received a methylene blue injection. A dangerous drug interaction could occur.
Rare cases of a condition called pulmonary hypertension as well as heart valve disease have been reported in patients taking Adipex-P. Stop Adipex-P immediately if you develop difficulty breathing or shortness of breath, feelings of lightheadedness like you might faint, swelling in your legs, chest pain, or fast heartbeat.
Phentermine Pregnancy Warnings
When administered to animals during late gestation at a dose 7 times the maximum human dose (MHD) on a mg/m2 basis, this drug had no adverse effects on the mothers or offspring; however, a dose 10 times the MRD on a mg/m2 basis abolished estrous cycling. There are no controlled data in human pregnancy.
AU TGA pregnancy category B2: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage.